🇺🇸 FDA
Patent

US 7662394

Nucleic acids encoding chimeric Flavivirus immunogens comprising the Japanese encephalitis virus (JEV) PRM signal sequence

granted A61KA61K2039/53A61K2039/70

Quick answer

US patent 7662394 (Nucleic acids encoding chimeric Flavivirus immunogens comprising the Japanese encephalitis virus (JEV) PRM signal sequence) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
47
CPC classes
A61K, A61K2039/53, A61K2039/70, A61K39/12, A61K48/00